Ingevity Corporation (NGVT), a performance chemicals company, has seen its share price incessantly sliding since April 2019. Amid the recent coronavirus pandemic-induced sell-off, the stock price plunged close to the 2016 spin-off level.
Meanwhile, the stock price slump by no means signifies the deep merits of this carbon market player are no longer relevant. With ~6.9x EV/2020 EBITDA, I believe the stock is cheap and might be worth considering by the GARP-oriented long-term investors even despite bleak 2020 prospects hamstrung by the global economic crisis. Also, consistent insider buying in